MS in the Media - 23 August 2019
17 - 23 August 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Diet in adolescence affects MS risk
What people eat during their teens may affect risk of MS later according to new research. People who were later diagnosed with MS had eaten less fish, poultry, eggs, fruit and veg and some dairy during their teenage years than a control group without MS.
Source: MS Research Australia
MS Trust link: Causes of MS
MRI results in CIS suggest MS risk
People who had more and larger lesions on MRI scans in the first year after diagnosis with clinically isolated syndrome (CIS) were more likely to go on to a diagnosis of MS according to Australian research. A separate study in people with CIS found signs of cognitive changes even at this early stage
Source: MS News Today
Source: MS Research Australia
MS Trust link: Clinically isolated syndrome (CIS)
Why finding new drugs for progressive MS is difficult
Barriers to finding treatments for progressive MS include incomplete understanding all of what causes progression, inadequate animal models of progressive MS and financial barriers, according to a review of the field
Source: EurekaAlert
MS Trust link: Ocrevus and other drugs in development for progressive MS
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
